Başak Ünver Koluman, Muhammet Arslan, E. Başaran, E. P. Eser, H. Özdoğu
{"title":"多发性骨髓瘤伴腹水1例","authors":"Başak Ünver Koluman, Muhammet Arslan, E. Başaran, E. P. Eser, H. Özdoğu","doi":"10.7197/cmj.947488","DOIUrl":null,"url":null,"abstract":"Ascites is an unusual finding of multiple myeloma. It is a sign of poor prognosis and can be seen not only at the initial diagnosis, but also at any stage of the disease. In this case report, we present the peritoneal involvement of a relapsed refractory multiple myeloma patient with Ig G lambda type. The patient was prescribed 2 cycles of lenalidomide (15 mg) and dexamethasone (20 mg). However, the patient did not respond to treatment.","PeriodicalId":10750,"journal":{"name":"Cumhuriyet medical journal","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Multiple myeloma case with ascites\",\"authors\":\"Başak Ünver Koluman, Muhammet Arslan, E. Başaran, E. P. Eser, H. Özdoğu\",\"doi\":\"10.7197/cmj.947488\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ascites is an unusual finding of multiple myeloma. It is a sign of poor prognosis and can be seen not only at the initial diagnosis, but also at any stage of the disease. In this case report, we present the peritoneal involvement of a relapsed refractory multiple myeloma patient with Ig G lambda type. The patient was prescribed 2 cycles of lenalidomide (15 mg) and dexamethasone (20 mg). However, the patient did not respond to treatment.\",\"PeriodicalId\":10750,\"journal\":{\"name\":\"Cumhuriyet medical journal\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cumhuriyet medical journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7197/cmj.947488\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cumhuriyet medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7197/cmj.947488","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
腹水是多发性骨髓瘤的罕见表现。这是预后不良的标志,不仅在最初诊断时可以看到,而且在疾病的任何阶段都可以看到。在这个病例报告中,我们提出了一个复发的难治性多发性骨髓瘤患者与Ig G λ型腹膜受累。患者给予来那度胺(15mg)和地塞米松(20mg)治疗2个周期。然而,患者对治疗没有反应。
Ascites is an unusual finding of multiple myeloma. It is a sign of poor prognosis and can be seen not only at the initial diagnosis, but also at any stage of the disease. In this case report, we present the peritoneal involvement of a relapsed refractory multiple myeloma patient with Ig G lambda type. The patient was prescribed 2 cycles of lenalidomide (15 mg) and dexamethasone (20 mg). However, the patient did not respond to treatment.